Teladoc Health Names Chuck Divita as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
BofA Securities Reiterates Neutral Rating on Teladoc (TDOC)
June 11, 2024 5:28 AM EDTBofA Securities analyst Allen Lutz reiterated a Neutral rating and $13.50 price target on Teladoc (NYSE: TDOC).
The analyst comments "Filling the CEO role will likely remove the overhang that has been driving investor questions on who will lead the company through the next phase of growth. Mr. Divita has broad experience driving growth and advancing new models... More
Citi Reiterates Neutral Rating on Teladoc (TDOC)
June 10, 2024 8:29 AM EDTCiti analyst Daniel Grosslight reiterated a Neutral rating and $15.50 price target on Teladoc (NYSE: TDOC).
The analyst comments "We had a chance to catch-up with TDOC mgmt this morning after the company announced Chuck Divita will be joining as CEO (LINK, 6/10). Chuck... More
